PreveCeutical Medical OTC Performance
| PRVCF OTC | USD 0.01 -0.0047 -32.64% |
The company has a Market Sensitivity (Beta) of -2.96, which means elevated sensitivity to broad market movements. A strongly negative beta means PreveCeutical Medical acts as a natural hedge, gaining when the broader market declines. At this point, PreveCeutical Medical has a negative expected return of -0.0961%.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days, PreveCeutical Medical generated negative risk-adjusted returns and added little value for investors with long positions. Current market capitalization is about 11.93 Million. Despite nearly stable fundamental indicators, PreveCeutical Medical is not utilizing all of its potential. The current price disturbance may contribute to mid-run losses for stockholders. Learn More
| Begin Period Cash Flow | 156.4 K | |
| Total Cashflows From Investing Activities | -52.7 K |
PreveCeutical |
Relative Risk vs. Return Landscape
If you had invested $ 1.62 in PreveCeutical Medical on December 27, 2025 and sold it today you would have lost $ 0.65 from holding PreveCeutical Medical or given up 40.12% of portfolio value over 90 days. PreveCeutical Medical is currently producing negative expected returns and carries 12.0984% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than PreveCeutical, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
The concept of mean reversion, where PreveCeutical OTC Stock price gravitates toward equilibrium, is fundamental to market analysis. This pattern is a cornerstone of many forecasting models, though periods of persistent mispricing occur. Investors demand compensation for the additional risk inherent in stocks that remain mispriced longer. The concept of price convergence is essential context for any investor forecasting PreveCeutical OTC Stock price direction.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 0.01 | 90 days | 0.01 | close to 99 |
Statistical modeling indicates that the probability of PreveCeutical Medical moving above the current price in 90 days from now is close to 99 . The historical return profile over this window has produced more above-current than below-current outcomes. (This stock distribution maps the range in which PreveCeutical OTC Stock has been most likely to trade over the next 90 days).
PreveCeutical Medical Price Density |
| Price |
Predictive Modules for PreveCeutical Medical
Accurately predicting the otc stock market is one of the most challenging tasks for investors analyzing PreveCeutical Medical. No single approach dominates, but the practice of forecasting remains an essential element of the investment process. Investors benefit from applying a variety of techniques rather than relying on a single model for PreveCeutical Medical. The practice of comparing forecasts for PreveCeutical Medical builds analytical resilience regardless of which model proves most accurate.Experienced investors tracking PreveCeutical Medical's watch for mean reversion setups where price has deviated from its long-run average. Sentiment extremes, news events, or liquidity shocks are common catalysts for these temporary dislocations in PreveCeutical Medical. Prices periodically overshoot their intrinsic value in both directions, creating mean reversion opportunities in PreveCeutical Medical. The mean reversion signal is most useful when combined with fundamental confirmation for PreveCeutical Medical's.
Primary Risk Indicators
Volatility has been a defining feature of the otc stock market in recent decades, and PreveCeutical Medical has reflected that pattern. Sudden corrections and sharp rallies have tested many portfolios that include PreveCeutical Medical. A risk management approach built around PreveCeutical Medical's volatility metrics can help investors manage downside exposure. Tracking PreveCeutical Medical's risk indicators over time reveals how the risk profile evolves across market cycles.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | -2.96 | |
σ | Overall volatility | 0.0023 | |
Ir | Information ratio | 0.04 |
Investor Alerts and Insights
For investors following PreveCeutical Medical, automated alerts provide early signals of meaningful shifts in stock dynamics. PreveCeutical Medical notifications highlight material changes that could affect portfolio decisions and overall risk exposure. Investors can customize PreveCeutical Medical alert parameters to match their risk tolerance and investment horizon. Pairing alerts with independent analysis strengthens conviction in PreveCeutical Medical investment decisions.| PreveCeutical Medical generated a negative expected return over the last 90 days | |
| PreveCeutical Medical has high historical volatility and very poor performance | |
| PreveCeutical Medical has some characteristics of a very speculative penny stock | |
| PreveCeutical Medical has a very high chance of going through financial distress in the upcoming years | |
| PreveCeutical Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| PreveCeutical Medical has accumulated $1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating PreveCeutical Medical may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt can serve as one financing mechanism for PreveCeutical to fund growth, though the effectiveness depends on borrowing costs and execution. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was -1.73 M with profit before overhead, payroll, taxes, and interest of 2.25 K. | |
| PreveCeutical Medical has accumulated about 2.64 K in cash with -426.39 K of positive cash flow from operations. | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders |
PreveCeutical Medical Fundamentals Growth
The pricing of PreveCeutical OTC Stock is heavily influenced by PreveCeutical Medical's fundamental performance over time. Investors monitor revenue growth, profit margins, cash flow generation, and debt management as key indicators. The performance of PreveCeutical OTC Stock is closely linked to PreveCeutical Medical's underlying financial metrics and growth rates. Profitability trends, cash flow generation, and capital structure remain the key fundamentals for PreveCeutical OTC Stock.
| Return On Asset | -3.31 | |||
| Current Valuation | 12.06 M | |||
| Shares Outstanding | 523.3 M | |||
| Price To Sales | 3,902 X | |||
| EBITDA | -1.28 M | |||
| Cash And Equivalents | 2.64 K | |||
| Total Debt | 1.68 M | |||
| Debt To Equity | 347.60 % | |||
| Book Value Per Share | -0.01 X | |||
| Cash Flow From Operations | -426.39 K | |||
| Earnings Per Share | -0.003 X | |||
| Total Asset | 161.2 K | |||
Performance Metrics & Calculation Methodology
Benchmark comparison for PreveCeutical Medical clarifies whether returns reflect stock-specific outcomes or market-wide trends. Outperformance relative to the benchmark may reflect exposure tilt, selection effect, or timing. PreveCeutical Medical shows ROA of -3.31%.
PreveCeutical Medical metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Not all fields update in real time. Return and risk statistics are calculated from historical price series.